The incremental predictive ability of NT-proBNP for CHD and stroke was greater than HDL cholesterol or CRP, and NT-proBNP could serve as a multipurpose biomarker in new approaches that integrate HF into CVD primary prevention. The gene discussed is NPPB; the disease is coronary artery disorder.